1.
Odierna GL, Phillips W. Targeting the safety factor for neuromuscular transmission to treat myasthenia gravis: Safety factor for neuromuscular transmission. rrnmf [Internet]. 2023 Aug. 29 [cited 2024 Jun. 16];4(3). Available from: https://journals.ku.edu/rrnmf/article/view/19543